"10.1371_journal.pone.0018120","plos one","2011-04-25T00:00:00Z","Stephen J Brett; Puja Myles; Wei Shen Lim; Joanne E Enstone; Barbara Bannister; Malcolm G Semple; Robert C Read; Bruce L Taylor; Jim McMenamin; Karl G Nicholson; Jonathan S Nguyen-Van-Tam; Peter J M Openshaw; the Influenza Clinical Information Network (FLU-CIN)","Centre for Peri-operative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, United Kingdom; Division of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom; Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Department of Health, Skipton House, London, United Kingdom; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom; Department of Infection and Immunity, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom; Department of Critical Care, Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom; Health Protection Scotland, NHS National Services, Glasgow, United Kingdom; Infectious Diseases Unit, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, United Kingdom; Centre for Respiratory Infections, National Heart and Lung Institute, Imperial College, London, United Kingdom","Conceived and designed the experiments: SJB PM WSL JEE BB MGS RCR BLT JM KGN JSN-V-T PJMO. Analyzed the data: SJB PM. Wrote the paper: SJB PM JSN-V-T PJMO.","SJB has received consultancy fees from Pfizer. WSL has received an unrestricted educational grant from Wyeth (now Pfizer). KGN has received H5 avian influenza vaccines from Novartis and pH1N1 influenza vaccines from GlaxoSmithKline and Baxter to facilitate MRC and NIHR-funded trials. He has received consultancy fees from Novartis and MSD. RCR is Chief Investigator of a vaccine trial funded by Novartis. JSN-V-T was one of several collaborators who jointly received an unrestricted educational top-up grant for previous statin-related research from Pfizer (in 2005), he also received consultancy fees in 2008 (for work unrelated to statins) from Novartis. PJMO is a member of the European Scientific Working Group on Influenza (ESWI), which is funded by the pharmaceutical industry. This does not alter the authors' adherence to all the PLOS One policies on data sharing and materials.","2011","04","Stephen J Brett","SJB",13,TRUE,12,NA,2,4,TRUE,TRUE,TRUE,1,"13",TRUE
